Conferences

International Perspectives On Setting Up Health Systems January 17, 2023

Physicians Addressing Climate Change January 15, 2023

The University of Michigan Youth Violence Prevention Center January 15, 2023

Health, Sustainability, Environmental Justice, and Moving a Health System to Carbon Neutrality January 15, 2023

When Public Health and Urology Intersect: Finding the Path Forward January 15, 2023

Into the Microverse of Prostate Cancer from Microenvironment's Immune Modulation to the Complexity of Tumour Heterogeneity January 10, 2023

ctDNA, Liquid Biopsy and Molecular Subtypes December 14, 2022

Imaging (R)evolution in GU Oncology December 13, 2022

GU Oncology State of the Art and Beyond December 12, 2022

Ongoing Clinical Trials in GU Oncology at San Raffaele University Hospital December 12, 2022

SUO 2022: Intermediate Risk Non-Muscle Invasive Bladder Cancer: “New” Definitions December 3, 2022

SUO 2022: Using Biomarkers and Somatic Testing to Guide Treatment Choice December 3, 2022

SUO 2022: Intermediate Risk: New Trials and Horizons December 3, 2022

SUO 2022: Geographic Variation in Utilization of Doublet Therapy for Metastatic Prostate Cancer December 3, 2022

SUO 2022: External Validation of a Digital Pathology-Based AI Model Predicting Metastasis and Death in High and Very High Risk Men on NRG/RTOG 9902 Phase III Trial December 3, 2022

SUO 2022: Looking Towards the Future: Non-Muscle Invasive Bladder Cancer Trials Reading Out in 24 Months December 3, 2022

SUO 2022: Utility of Cxbladder Monitor in Surveillance December 3, 2022

SUO 2022: BCG Naïve - FDA: 1 Year from Symposia December 3, 2022

SUO 2022: “Remote” Monitoring in Urologic Cancer: The Case for Home Based Testing in Bladder Cancer December 3, 2022

SUO 2022: Revisiting Neoadjuvant Therapy Before Prostatectomy December 2, 2022

Page 1 of 492

email news signup